"VFS": olelo ao no ka hoʻohana. Analogs, hōʻike manaʻo a me nā contraindications "VFS"

"VFS" papa i ka mua papa pae o antiarrhythmic konohiki. A lāʻau hiki o ka paleʻana paʻakai kaha ma membranes o cardiomyocytes. Ua hoʻonāukiukiʻana mai o ka meheu o intraventricular a atrioventricular conduction hoʻopōkole 'oe i iaea ooieoeiiaeuiiai pono a me ka refractory manawa i loko o ka atria, laulau lala aeie, af-wahi a Purkinje olona. O ia hoʻi, loa ole ia ma luna o ka lōʻihi like 'ole o ka QT-wā mawaena, alapine (frequency) o contractions. I ka wa e kaawale aku o ka loiloi mua hoikeana o lawa cardiac hana, lāʻau "VFS" (manual he mea 'ike) i ole ia ma myocardial contractility. Ua aʻole e pili mai ka conductivity o ka atrioventricular wahi anterograde ao ao. Hope paha, aole adverse hypotensive hopena. Ma ka hana pono ka mea, ua i ia inotropic keiki. I ka loaa ana o ka ka lapaʻauʻia ua i inhibited i loko o ka sinus wahi automaticity. Ua he antispasmodic, kūloko anesthetic, a me ka lōpū anticholinergic hana ka ole lapaʻau manaʻo nui loa. Ua loaʻa iki koronarorasshiryayuschee, kiaha dala waiwai. Ke kanawai o ke ku una ha mark kanaha a kanaono minuke. ma hope o 80 minuke Ua hiki i kā mākou hope. Ka lōʻihi like 'ole o ka pākōlea hana - e 8 hola.

Pharmacokinetics ma kekahi mau hihia

Ke bioavailability o ka hola 40%. Ka lāʻau 'Ua metabolized i loko o ke ake, a mea hiki ke komo iloko o ka BBB. Excretion o ka lāʻau ia lŘlŘ i loko o ka mimi. I ka 'aʻe' ana iʻaʻa puʻuwai hana au o ka excretion ua mahuahua ma 2-3 manawa.

He aha o ia hoʻi, "VFS" nāʻikepili no ka hoʻohana?

Ka lāʻau 'Ua hōʻike no ka ventricular a me supraventricular extrasystoles, paroxysmal tachycardia a me ka' ano (ʻaʻohe lesions i loko o ka naʻau o ka ke aloha ano a me ka maʻi pale WPW), atrial koliliʻana a me ka atrial paroxysms.

dosing regimen

E hoomakaukau ai "VFS" manual ia kekahi i kekahi mahele lāʻau - 25 mg 1 manawa no 8 hola. I ka wa e kaawale aku o ka hookahua pākōlea hopena medicament ia kela 6 hola. Ma kekahi manawa ae e ala palua hookahi mahele lāʻau (50 mg). Ka manawa wā mawaena o keia hihia, he 6-8 hola.

I ka lā i ka i kā mākou 'ae' ole hou aku 300 mg. Ka lōʻihi like 'ole o ka Inc a me ka expediency? Iaea huakai kaapuni e loaa ana i ka ahaaina i hoʻomalu. Medicine inu ma hope o kaʻai. Pulverize a hahi i ka hoʻopololei ua i aeia.

Medicament "VFS":ʻaoʻao loa

Ke kumuhana Ke i ke kauka i ka kuhikuhi lāʻau tolerated e hoʻomanawanui iki mai o nā makahiki, he maikai nui iho la ia. Eia naʻe, aia no he manawa kūpono no adverse 'ole ma ke kumu o ka lāʻau Inc "VFS". ʻaoʻao 'ole ke pela i loli iki degere o ka oolea. Ka hope ke hoʻonāukiuki haunaele i loko o nā hana o kaʻike ākea, a Central ko mākou hopohopo nenoai. I ka nui, eia pōniuniu, diplopia, ataxia. Mawaena o ka hopena maikaʻi ka hopena o ka hopena o ka lāʻau ma luna o ka mea'ōnaehana mānowai koko'ōnaehana mākaukau e hoailona oukou'ē aʻe aʻe 'o intraventricular a me ka atrioventricular conduction, i ka ulu ana o ka sinus tachycardia (me ka lōʻihi-makahiki lapaau). Adverse hoikeana nā arrhythmogenic hookoia, ke hooloihiia mai o QP-huahelu,? Anoe o na QRS-luna 'a me nā loli i loko o ka ECG kumu. Ma ke kumu o ka lāʻau Inc "VFS" (manual ao mai e pili ana ia) akaka redness o kaʻili, eha ma ke poo a me ka manao o ke kaumaha. Kekahi hoʻomanawanui iki mai ka mahina i ka allergic naoh (lapuwale ia a ili ae hookaawale). Ua kekahi mau 'ike e pili ana i ka adverse hopena o ka lapaʻauʻia "VFS" manual. Reviews 'Oihana e pili ana i portability mea, ma ka mau, maikaʻi. Naʻe, haawiia i ke koʻikoʻio o kekahi o ka hopena maikaʻi ka hopena o ka lāʻau ua lawe mai ma lalo o ka pili hooponopono ana o ke kauka.
Ma ka hanana o complications a me ka mea hōʻemi lakou e ike koke kipa i ka hoʻomalu. Ma keia hihia, ke kauka e koho ma ka hakahaka o ia hoʻi, "VFS" like ai '.

I ka wā i hāʻawi ai i ka lapaʻauʻia?

Contraindications nā cardiogenic kŰia, atrioventricular aeie i loko o ke kolu a me ka lua o ke kahua (i loko o ka wa e kaawale aku o ka Keaukaha kaʻimi hoʻopunipuni naau pāpana). Ua ua i ae e inu i ka laau no hypertension i loko o ka pilikia au (systolic puʻe emi o 90 mm o / Hg.), Hypertrophy ma ka myocardium o ka hema ventricle'ōlelo ai. Banned ai 'i loko o ka lāʻau kū-infarction cardiosclerosis. Ka lāʻau 'ua ole e waiho no ka blockade o ka akau wāwae laulau lala hihia (wā hui me kāna hana i loko o ka lala ma kaʻaoʻao hema), maʻi hoʻokō' ole 'papa naʻau lōpū a me ka loa. Contraindicated ka lapaʻauʻia i ka makahiki 18 (aie i ka mea i ka mea, ua ole hookupaaia ka maluhia a me ka hopenaʻoi loa o Luna), fructose intolerance. Ua ua i ae e lawe i ka ka lapaʻauʻia no ka poʻe me ka maʻi pale o ka hoʻopōʻino resorption galactose / monakō koko, hāpai keiki, isomaltase nele / sucrose. 'Aʻole i paipai lāʻau no hypersensitivity i na eiiiiiaiou. Inā 'oe makemake e pana aku au i kekahi keikiʻai Inc i ka hoomanawanui, e makemake e hooki lactation.

I ka wa e pono i ka mahele lāʻau hoʻoponopono?

I kekahi manawa, he mea i pono, e hoʻololi hana "VFS" loaa ana puni. Na Ke Kumu, loa mai o ka poe akamai i komo 'ike i emi ai ka nui o ka lāʻau a me ka hoonui i ka wā mawaena ma waena o nā māhele hiki ke paipai me atrioventricular hina ma ke degere mua, ma intraventricular conduction kāna hana, bradycardia. E haʻalele aku like me ka huina-panina glaucoma, circulatory kāna hana (ʻike ākea) kaumaha ano hypertrophy ma prostate nā'aʻaʻa. ? Iaea i puhi ai pono ma luna o ke kumu o ka electrolyte pūnao hoʻololi conductivity ma Purkinje olona, blockade o kekahi o nā wāwae i loko o ka pua lala hihia. Mālama nui ua pono ai ka wā i loaʻa ai nā lapaʻauʻia antiritmicheskih ka poʻe me ka lapaau "VFS". Reviews o na poe akamai i ka loa hoʻopaʻakikīʻia ka naʻau ma luna o ke kahe o ka loli ma ka laʻau heluna i ole ia.

No ka 'ike hou aku,

Mua e hoʻomaka ana i ka Inc eliminates kāna hana o ka wai a me ka electrolyte koena ma ke kaʻina hana o ka loaa ana i ka ka lapaʻauʻia mea pono e hōʻoia i ka ikaika a me ka manao e hooponopono no ia. cardiac stimulation paepae e mahuahua ma ka hoomanawanui i ka poe i loaa i ka naau kaua (huʻi), naau e hemahema, a i kaʻimi hoʻopunipuni pacemaker. Ma ka hanana o ka pōniuniu, papalua hihiʻo, headaches waiho e emi i ka laʻau heluna. I ka wā o ka sinus tachycardia ma ke kumu o ka lōʻihi? Eaia lāʻau Hoʻokolohua-blockers i hāʻawi i pono. Mau hoomakaukau i paipai i ka haahaa nā māhele. Ma ke kumu o ka iapaau ana pono e akahele ka wā hana palena papaha hoʻopōʻino hana i ka pono, a mahuahua nui noonoo ana a me ka kokololio lehulehu a naoh.

overdose

Aie i ka mea i ka lāʻau i ka haʻahaʻa laulā o pākōlea haʻawina, loa intoxication hiki i hoʻomaka ai eaaei lawa. No kiʻekiʻe pilikia o kaʻapu kōheoheoʻana ma ka loaʻa mua o nā antiarrhythmic ai '. I overdose ia elongation PR- a me QT-ʻanuʻu, amplitudes hoomahuahua T-nalu? Anoe? QRS-luna '. E kū'ē i ke kāʻei kua o ka intoxication aicieeaao asystole, bradycardia, ua hoʻemi contractility i loko o ka myocardium. Ke hoomanawanui Ua pū akula nō hoʻi sinotrialnaya blockade, hoemi i ka'aloʻahiʻa haʻi, digestive nenoaiu kāna hana. Intoxication ua pu ma paroxysmal polymorphic ventricular tachycardia, blurred hihiʻo, pōniuniu, eha ma ke poo. Ma ka hanana o ka overdose symptomatic kanaka ua hōʻike. Lapaʻau o ventricular tachycardia ua lawe mai me ka hoʻohana 'antiarrhythmic ai' waeʻano o I A a me I C oʻAmelika Hui QRS-eiiieaena, hypotension a me ka bradycardia eliminated paʻakai hydrogen kalepona.

AaOIeIOUIeXAOAaIN me nā medicaments

I ka lawe pu me inducers o hepatic microsomal nā'ūhū lāʻau hopenaʻoi loa "VFS" emi iho. Kēia maoli i ka pilikia o kaʻawahia loa. I ka loaa ana antiarrhythmic ai 'o nā papa mahuahua likelihood o ka ulu arrhythmogenic keiki. Ka mea paahana kekahi hoʻokāʻoi aʻe ana i ka ha awina o ka ole-depolarizing Muscle relaxants.

A he mea he pono ka lāʻau me ka likeʻano papa hana o ka hana?

O ia hoʻi, "Allaritmin" iloko ona i kakauia na iaʻeleu waiwai me ka lapaau "VFS" - lappaconitine hydrobromide. Ke medicament pili ana i ka papa aʻu antiarrhythmic ai '. "Allaritmin" ka lapaau Ua loaʻa ma ka papa palapala, a me ka pāʻoihana i ka pahu kui i loko o ka Muscle a me ka aa koko. I ka lawe hōʻike waha, ka medicament hookoia ia lŘlŘ i loko e pili ana i ka hora. Ma hope o 4-5 hola, he i kā mākou ka hoʻokōʻana ihoiho. Duration o ka hookoia - 8 hola a oi. I ka hoike ana o ka politika kanawai o ka lāʻau ia lŘlŘ hoʻomaka koke - i loko o 15-20 minuke. Haʻalele medicament "VFS" 'o ia hoʻi "Allaritmin" paipai inu 3 manawa kela la i keia 25 mg. E lawe i ka lapaau e ia ma mua ai. Papa i makemakeia e hoea. I Ina o ka nele o ka hopenaʻoi loa i ke mahuahua laʻau heluna a me ka alapine (frequency) o? Eaia. Intravenous aaieieno? Ua lawe mai lohi, no 5 minuke. Laʻau heluna pela i kau e like me ke kaumaha o ka hoʻomanawanui. Paipai e 0.3-0.4 mg / kg. Ma kekahi hihia (pakahi aku la ia loa) lāʻau lawelawe pinepine ae la oia maluna o 6 hola. I Muscle lawelawe 0,4 mg / kg maʻanuʻu o ka 6 hora. Ua Ua kaulana ia intravenous aaieieno? Ua i? Aeiiaiaoaony e lawe mai ma ka hale. Uluwehi O "Allaritmin" i ka ia kapu ma ka hoʻohana like me ka lapaau "VFS". Lapaʻau ua lawe mai i loko o ka haukapila ma lalo o mau hooponopono ana o ka lapaau a me ECG ka mālamaʻana. He mea nui kēia oi loa ma ka iapaau ana o nā mea maʻi me ka mua iho atrioventricular aeie, naau e hemahema, decompensated maʻi papa type.

ka hopena

O ia hoʻi, "VFS", ka hoʻohana 'ana i pono e malama ikaika lāʻau, e like nā antiarrhythmics, e pili ana i ka waeʻano o potent ai'. I ka wa e kaawale aku o pākōlea hookoia e ole hoʻonui kona iho, i ka wa e lawe i ka hoakakaia laʻau heluna o ka hoʻomalu. O ke kumu ho i ka mea i loaʻa o ka pilikia o ka intoxication, a mahope complications. Mua oe hāʻawi i ka lāʻau, i ke kauka e kau aku i ka hoʻomanawanui ike o ka hikiʻaoʻao waiwai a me contraindications. I huli ai oe, i ka hoʻomanawanui e haʻi ana i ka alo o ka intolerance, a me ka moʻolelo, ma kekahi Media, e like me ka ai 'i ia ai keu. Ma mua o ka lawe i kēia ka lapaʻauʻia e e kaupaona i nā annotation.